Results
|
3861.
|
|
|
3862.
|
Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression. [electronic resource] by
- Turner, Kristen M
- Sun, Youting
- Ji, Ping
- Granberg, Kirsi J
- Bernard, Brady
- Hu, Limei
- Cogdell, David E
- Zhou, Xinhui
- Yli-Harja, Olli
- Nykter, Matti
- Shmulevich, Ilya
- Yung, W K Alfred
- Fuller, Gregory N
- Zhang, Wei
Producer: 20150604
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 112
Availability: No items available.
|
|
3863.
|
|
|
3864.
|
|
|
3865.
|
MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers. [electronic resource] by
- Gutenberg, A
- Bock, H C
- Brück, W
- Doerner, L
- Mehdorn, H M
- Roggendorf, W
- Westphal, M
- Felsberg, J
- Reifenberger, G
- Giese, A
Producer: 20140717
In:
British journal of neurosurgery vol. 27
Availability: No items available.
|
|
3866.
|
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study. [electronic resource] by
- Hummel, Trent R
- Wagner, Lars
- Ahern, Charlotte
- Fouladi, Maryam
- Reid, Joel M
- McGovern, Renee M
- Ames, Matthew M
- Gilbertson, Richard J
- Horton, Terzah
- Ingle, Ashish M
- Weigel, Brenda
- Blaney, Susan M
Producer: 20130923
In:
Pediatric blood & cancer vol. 60
Availability: No items available.
|
|
3867.
|
|
|
3868.
|
|
|
3869.
|
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. [electronic resource] by
- van den Bent, Martin J
- Klein, Martin
- Smits, Marion
- Reijneveld, Jaap C
- French, Pim J
- Clement, Paul
- de Vos, Filip Y F
- Wick, Antje
- Mulholland, Paul J
- Taphoorn, Martin J B
- Lewis, Joanne
- Weller, Michael
- Chinot, Olivier L
- Kros, Johan M
- de Heer, Iris
- Verschuere, Tina
- Coens, Corneel
- Golfinopoulos, Vassilis
- Gorlia, Thierry
- Idbaih, Ahmed
Producer: 20190506
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
3870.
|
|
|
3871.
|
|
|
3872.
|
|
|
3873.
|
|
|
3874.
|
|
|
3875.
|
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer. [electronic resource] by
- Farago, Anna F
- Yeap, Beow Y
- Stanzione, Marcello
- Hung, Yin P
- Heist, Rebecca S
- Marcoux, J Paul
- Zhong, Jun
- Rangachari, Deepa
- Barbie, David A
- Phat, Sarah
- Myers, David T
- Morris, Robert
- Kem, Marina
- Dubash, Taronish D
- Kennedy, Elizabeth A
- Digumarthy, Subba R
- Sequist, Lecia V
- Hata, Aaron N
- Maheswaran, Shyamala
- Haber, Daniel A
- Lawrence, Michael S
- Shaw, Alice T
- Mino-Kenudson, Mari
- Dyson, Nicholas J
- Drapkin, Benjamin J
Producer: 20200812
In:
Cancer discovery vol. 9
Availability: No items available.
|
|
3876.
|
Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686. [electronic resource] by
- Boxerman, Jerrold L
- Zhang, Zheng
- Safriel, Yair
- Rogg, Jeffrey M
- Wolf, Ronald L
- Mohan, Suyash
- Marques, Helga
- Sorensen, A Gregory
- Gilbert, Mark R
- Barboriak, Daniel P
Producer: 20190930
In:
Neuro-oncology vol. 20
Availability: No items available.
|
|
3877.
|
Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma. [electronic resource] by
- Han, Bo
- Cai, Jinquan
- Gao, Weida
- Meng, Xiangqi
- Gao, Fei
- Wu, Pengfei
- Duan, Chunbin
- Wang, Ruijia
- Dinislam, Magafurov
- Lin, Lin
- Kang, Chunsheng
- Jiang, Chuanlu
Producer: 20190128
In:
Cancer letters vol. 419
Availability: No items available.
|
|
3878.
|
|
|
3879.
|
|
|
3880.
|
|